Related Experiment Videos
Cancer and the cell cycle. Lausanne, Switzerland, January 17-20, 1996
1Istituto Mario Negri, Milan, Italy.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
Genetic markers for prediction of treatment outcomes in ovarian cancer.
The pharmacogenomics journal·2014
Seminars in clinical pharmacology: an introduction to MET inhibitors for the medical oncologist.
Annals of oncology : official journal of the European Society for Medical Oncology·2012
RAS/RAF/MEK inhibitors in oncology.
Current medicinal chemistry·2012
Sofetabart mipitecan, an antibody drug conjugate targeting folate receptor alpha, in high grade ovarian cancer: Results from the first-in-human phase 1 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Efficacy of Cryotherapy in Preventing Taxane-Induced Neuropathy: The CryoPac Randomised Controlled Trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Final results and predictive biomarkers of response and long-term outcomes with first-line pembrolizumab monotherapy in advanced renal cell carcinoma in the phase II KEYNOTE-427 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase Ib study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Risk-Informed Self-Care for Recurrence Risk Reduction among Breast Cancer Survivors: A Concept Analysis for Nursing Language Development.
International journal of nursing knowledge·2026
The Impact of Statin Therapy on Postoperative Short- and Long-term Mortality and Morbidity After Non-Cardiac Surgery.
European journal of preventive cardiology·2026
Progression to castration-resistance and metastatic disease following androgen deprivation therapy for biochemical recurrence after prostate cancer surgery.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Integrating Polygenic Risk Score, Sex, and Family History to Personalize the Initial Screening Age for Colorectal Cancer.
International journal of cancer·2026